Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




JNC8 and ESH Guidelines Are Due This Year. Will They Agree?
Link ID 18867
Title JNC8 and ESH Guidelines Are Due This Year. Will They Agree?
Url http://www.medscape.com/viewarticle/706466?src=rss
Description Henry Black, MD, speculates on the upcoming hypertension guidelines from JNC8 and ESH. Medscape Cardiology
Category Articles > Cardiology
Keywords
Date Sep 26, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Quitting Smoking Ups Short-Term Risk of Type 2 Diabetes in ARIC Analysis
  Weight gain appeared to be at least one mechanism behind the increased risk; as there are plenty of excellent reasons to kick the habit, smoking cessation should be accompanied by efforts to control weight and other risk factors for diabetes, say researchers. Heartwire
Category:   Articles > Cardiology


2. Effects of Vitamin E on Stroke Subtypes: Meta-Analysis of Randomised Controlled Trials
  Vitamin E supplements are widely believed to be inoccuous, but this meta-analysis indicates that they may be associated with an increased risk of specific types of stroke. British Medical Journal
Category:   Articles > Cardiology


3. Smokers Who Quit Stay at Increased Risk of Atrial Fib
  Current and former cigarette smokers both had independently elevated risks of atrial fibrillation in a prospective, European population-based study. Heartwire
Category:   Articles > Cardiology


4. Researchers to Hunt Genes for Chinas High CholesterolResearchers to Hunt Genes for Chinas High Chole
  Researchers in Hong Kong are embarking on a study to identify genes that are responsible for high cholesterol and heart disease in patients in southern China, which they hope will pave the way for the design of better drugs. br / iReuters Health Information/i
Category:   Articles > Cardiology


5. FDA Panel Flunks Qnexa Because of Safety Concerns
  A somewhat conflicted Endocrinologic and Metabolic Drugs Advisory Committee has voted against approving the obesity drug Qnexa, expressing concerns about its safety. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS